African Green Monkey PBMC

<strong>African Green Monkey PBMC</strong>_x000D_ <strong>Catalog number:</strong> B2014553_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 Million Cells/vial_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Suspensions_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> African Green Monkey PBMC_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Wetzel KS, Yi Y, Elliott STC, Romero D, Jacquelin B, Hahn BH, Muller-Trutwin M, Apetrei C, Pandrea I, Collman RG. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections J Virol. 2017 Jan 31;91(4):e01626-16._x000D_ 2: Wetzel KS, Yi Y, Elliott STC, Romero D, Jacquelin B, Hahn BH, Muller-Trutwin M, Apetrei C, Pandrea I, Collman RG. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections J Virol. 2017 Jan 31;91(4):e01626-16._x000D_ 3: Riddick NE, Wu F, Matsuda K, Whitted S, Ourmanov I, Goldstein S, Goeken RM, Plishka RJ, Buckler-White A, Brenchley JM, Hirsch VM. Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors J Virol. 2015 Dec 9;90(5):2316-31._x000D_ 4: Cox BL, Schiffer H, Dagget G Jr, Beierschmitt A, Sithole F, Lee E, Revan F, Halliday-Simmonds I, Beeler-Marfisi J, Palmour R, Soto E. Resistance of Klebsiella pneumoniae to the innate immune system of African green monkeys Vet Microbiol. 2015 Mar 23;176(1-2):134-42._x000D_ 5: Gnanadurai CW, Pandrea I, Parrish NF, Kraus MH, Learn GH, Salazar MG, Sauermann U, Töpfer K, Gautam R, Münch J, Stahl-Hennig C, Apetrei C, Hahn BH, Kirchhoff F. Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys J Virol. 2010 Dec;84(23):12245-54._x000D_ 6: Horton MS, Minnier M, Cosmi S, Cox K, Galli J, Peters J, Sullivan N, Squadroni B, Tang A, Fridman A, Wang D, Chen Z, Vora KA. Development of a microneutralization assay for HSV-2 J Virol Methods. 2021 Nov;297:114268._x000D_ 7: Müller MC, Barré-Sinoussi F. SIVagm: genetic and biological features associated with replication Front Biosci. 2003 Sep 1;8:d1170-85._x000D_ 8: Beer B, Scherer J, zur Megede J, Norley S, Baier M, Kurth R. Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys Virology. 1996 May 15;219(2):367-75._x000D_ 9: Holzammer S, Holznagel E, Kaul A, Kurth R, Norley S. High virus loads in naturally and experimentally SIVagm-infected African green monkeys Virology. 2001 May 10;283(2):324-31._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31079199">10: Lopes LQS, de Oliveira PSB, de Souza Filho WP, de Almeida Vaucher R, Giongo JL, Sagrillo MR, Santos RCV. Glycerol monolaurate nanocapsules for biomedical applications: in vitro toxicological studies Naunyn Schmiedebergs Arch Pharmacol. 2019 Sep;392(9):1131-1140. </a>_x000D_ _x000D_ <strong>Products Related to African Green Monkey PBMC can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>